| Long name: |
Recombinant Macaca fascicularis 15-hydroxyprostaglandin dehydrogenase [NAD (+) ] (HPGD) |
| Alternative names: |
15-hydroxyprostaglandin dehydrogenase [NAD(+)], 15-hydroxyprostaglandin dehydrogenase [NAD(+)], 15-hydroxyprostaglandin dehydrogenase [NAD(+)], Prostaglandin dehydrogenase 1, Prostaglandin dehydrogenase 1, hypothetical protein, prostaglandin dehydrogenase I, 15-hydroxyprostaglandin dehydrogenase |
| Gene name: |
HPGD |
| Other gene names: |
15-PGDH, 15-PGDH, HPGD, PGDH1, PGDH1, HPGD |
| General description: |
All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, 15-hydroxyprostaglandin dehydrogenase [NAD (+) ] (HPGD) is a recombinant protein expressed in Yeast |
| Product category: |
Recombinant Proteins |
| Expression system: |
Yeast |
| Available also expressed in:: |
Baculovirus , Mammalian Cell, Yeast , E Coli |
| Purity: |
Greater than 90% (determined by SDS-PAGE) |
| Form: |
Lyophilized protein |
| Storage: |
Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius |
| Applications: |
IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA |
| Gene target: |
Macaca fascicularis 15-hydroxyprostaglandin dehydrogenase [NAD + ] (HPGD) |
| Short name: |
Macaca fascicularis 15-hydroxyprostaglandin dehydrogenase [NAD (+) ] (HPGD) |
| Alternative name: |
Macaca fascicularis 15-hydroxyprostaglandin dehydrogenase [Nicotinamide adenine dinucleotide (and) ] (hydroxyprostaglandin dehydrogenase 15-(Nicotinamide adenine dinucleotide)) |
| Alternative to gene target: |
15-PGDH and PGDH and PGDH1 and PHOAR1 and SDR36C1, BT, HPGD and IDBG-44946 and ENSG00000164120 and 3248, Hpgd and IDBG-155950 and ENSMUSG00000031613 and 15446, NAD+ binding, Plasma membranes, this GO :0003824 and catalytic activity and molecular function this GO :0004957 and prostaglandin E receptor activity and molecular function this GO :0005829 and cytosol and cellular component this GO :0006693 and prostaglandin metabolic process and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007565 and female pregnancy and biological process this GO :0007567 and parturition and biological process this GO :0008152 and metabolic process and biological process this GO :0016323 and basolateral plasma membrane and cellular component this GO :0016404 and 15-hydroxyprostaglandin dehydrogenase (NAD+) activity and molecular function this GO :0016491 and oxidoreductase activity and molecular function this GO :0019369 and arachidonic acid metabolic process and biological process this GO :0019371 and cyclooxygenase pathway and biological process this GO :0019372 and lipoxygenase pathway and biological process this GO :0030728 and ovulation and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0044281 and small molecule metabolic process and biological process this GO :0045786 and negative regulation of cell cycle and biological process this GO :0050662 and coenzyme binding and molecular function this GO :0051287 and NAD binding and molecular function this GO :0055114 and oxidation-reduction process and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070403 and NAD+ binding and molecular function this GO :0070493 and thrombin receptor signaling pathway and biological process this GO :0097070 and ductus arteriosus closure and biological process this GO :2001300 and lipoxin metabolic process and biological process, this GO :0003824 : catalytic activity, this GO :0003824 : catalytic activity and also this GO :0004957 : prostaglandin E receptor activity and also this GO :0016404 : 15-hydroxyprostaglandin dehydrogenase (NAD+) activity and also this GO :0016491 : oxidoreductase activity and also this GO :0042803 : protein homodimerization activity and also this GO :0050662 : coenzyme binding and also this GO :0051287 : NAD binding and also this GO :0070403 : NAD+ binding, this GO :0004957 : prostaglandin E receptor activity, this GO :0016404 : 15-hydroxyprostaglandin dehydrogenase (NAD+) activity, this GO :0016491 : oxidoreductase activity, this GO :0042803 : protein homodimerization activity, this GO :0050662 : coenzyme binding, this GO :0051287 : NAD binding, this GO :0070403 : NAD+ binding, 43717 and IDBG-629346 and ENSBTAG00000025942 and 512259, hydroxyprostaglandin dehydrogenase 15-(NAD) |
| Identity: |
5154 |
| Gene: |
HPGD |
More about : HPGD |
| Long gene name: |
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| Synonyms: |
SDR36C1 |
| Synonyms name: |
member 1 , short chain dehydrogenase/reductase family 36C |
| Locus: |
4q34, 1 |
| Discovery year: |
1991-07-16 |
| Entrez gene record: |
3248 |
| Pubmed identfication: |
19027726 |
| Classification: |
Short chain dehydrogenase/reductase superfamily |
| Havana BLAST/BLAT: |
OTTHUMG00000160772 |